How does Martin Lustgarten Ensure Results for His Clients?

Martin Lustgarten sees new client portfolios every day, and he must ensure his clients are given only the best service when they visit him for the first time. He pulls together quite a few different investment techniques that will produce results, and this article explains how he helps everyone find their way in the investing world. Martin understands what it takes to make money as an investor, and he trains his clients to make decisions just as he would.

#1: Martin Teaches His Clients To Think Like Investors

Every investor working with Martin learns what it means to look at the economy as an investor. A proper investor has a long-range view of everything, and they make choices that involve their position in the future. Maintaining their position for the future is more important than making a quick dollar today, and Martin shares his own philosophy for making money.

#2: Martin Turns Around Each New Client Portfolio

The portfolios may be quite difficult to untangle when Martin meets someone for the first time, and he believes it is possible for any client to start anew. He may divest a client from investments that are not appropriate, and he will begin a new investment stream that sends their money to new places.

#3: The Plans Offered By Martin Are Time-Tested

Martin has been investing for some time, and his techniques have been tested over and over again. He works quite hard on his own portfolio, and he simply applies what he knows to his clients and their portfolios. He believes a client will make quite a lot of money when they are following his tactics, and he may send them around the world to different markets that are not necessarily stocks. Martin has trained clients to invest in foreign debt, precious metals and currencies.

Each new client who visits Martin Lustgarten will find it quite helpful to learn what is wrong with their investments today. They will see how they may change things, and they will begin learning what the purpose of their investments must be. Martin shines a light on each investment to ensure it has meaning.

 

Laidlaw & Company Was Subjected To A Double-Edged Sword When Relmada Therapeutics Filed Amended Protests Bare 2 Months After Filing The Official Lawsuit.

Relmada Therapeutics Inc, a clinical stage pharmaceutical company previously filed a Lawsuit Against Laidlaw & Company in the Nevada District Court. Relmada Therapeutics Inc has already filed a motion to amend the same Lawsuit in a nail-biting pronouncement. The amended protest rubs salt to an already wounded Laidlaw by inclusion of additional legal claims. Relmada Therapeutics claims Laidlaw & Company infringed on the fiduciary duty by divulging confidential information it was entitled to through proxy entities in the course of representing Relmada as its investment banker.

Relmada Therapeutics wants further compensation for expenses (costs and fees) incurred in the course of addressing the untrue allegations leveled by Laidlaw & Company through proxy entities in December of 2015. Relmada Therapeutics elaborated that the Nevada District Court had beforehand subjected Laidlaw to a short-term restraining order and instituted sanctions against its top executives including Matthew Eitner and James Ahern. The restraining order and sanctions were due to Laidlaw executives’ distribution of inaccurate and untrue information. Relmada Therapeutics board of directors holds the opinion that Laidlaw & Company must be held accountable and ordered to cover the costs associated with Lawsuits and reputation. They also argue that Laidlaw & Company must be prohibited from causing the same damage to Relmada Therapeutics moving forward.
About Laidlaw & Company

Laidlaw & Company (UK) Ltd is a privately-held investment boutique/bank dedicated to offering an array of transparent and independent investment guidance, alternative investment solutions and high-end customer service to high-value institutions and personalities in the US and UK. The company is headquartered in New York with over 200 employees. The top executives of Laidlaw & Company include Mr. Matthew D. Eitner(Chief Executive Officer), Mr. James P. Ahern (Managing Partner and Head of Capital Markets), Mr. Hugh Regan (Executive Director of Investment Banking and Head of Laidlaw Private Equity), Mr. Craig Bonn (Senior Managing Director) and Mr. Hugh J. Marasa (Senior Managing Director, Private Placements)

Sources:

http://www.prnewswire.com/news-releases/relmada-therapeutics-files-amended-complaint-against-laidlaw-and-its-principals-matthew-eitner-and-james-ahern-300209454.html